Elevai Labs, Common Stock (ELAB) Earnings
Price: $5.64
Market Cap: $3.26M
Market Cap: $3.26M
Revenue (TTM): $1.71M
Net Income: $-4.30M
Net Income: $-4.30M
P/E Ratio: -22.85
EPS (TTM): $-0.25
EPS (TTM): $-0.25
Earnings Dates
Elevai Labs, Common Stock (ELAB) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: April 04, 2025
- Time of Day: Before Market Open
- Estimated EPS: $N/A
Last Earnings Report
- Date: November 13, 2024
- EPS: $-97.97
- EPS Estimate: $None
Elevai Labs, Common Stock's next earnings report is scheduled for April 04, 2025.
In its last earnings report on November 13, 2024, Elevai Labs, Common Stock reported earnings per share (EPS) of $-97.97, compared to an estimated EPS of $-. The company reported revenue of $527.48K, compared to an estimated revenue of $-.
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|
Earnings History
| Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
|---|---|---|---|---|
| November 13, 2024 | $-97.97 | $ | $527.48K | $- |
| August 14, 2024 | $-111.97 | $ | $605.53K | $- |
| May 15, 2024 | $-111.97 | $ | $614.56K | $- |
| March 29, 2024 | $-111.97 | $ | $698.59K | $- |
| December 11, 2023 | $-0.08 | $ | $316.53K | $- |
| September 29, 2023 | $-0.05 | $ | $554.65K | $- |
| March 30, 2023 | $-0.06 | $ | $142.82K | $- |
| December 29, 2022 | $-0.07 | $ | $138.90K | $- |
| September 29, 2022 | $-0.03 | $ | $432.12K | $- |
Annual Earnings
Annual Revenue
$1.71M
Fiscal Year 2023Annual Net Income
$-4.30M
Fiscal Year 2023Annual EPS
$-0.40
Fiscal Year 2023Quarterly Earnings
Revenue
$527.48K
Quarter Ending September 30, 2024Net Income
$-1.50M
Quarter Ending September 30, 2024EPS
$-0.07
Quarter Ending September 30, 2024Earnings Metrics
Earnings Yield
-0.11%
Year Ending December 31, 2023P/E Ratio
-914.33
Year Ending December 31, 2023Revenue Per Share
$0.16
Year Ending December 31, 2023Earnings Yield (TTM)
-4.38%
Trailing Twelve MonthsP/E Ratio (TTM)
-22.85
Trailing Twelve MonthsRevenue Per Share (TTM)
$0.11
Trailing Twelve MonthsFrequently Asked Questions
Elevai Labs, Common Stock's next earnings date is scheduled for April 04, 2025. The earnings call is expected to take place before market open.
In its last earnings report on November 13, 2024, Elevai Labs, Common Stock reported earnings per share (EPS) of $-97.97, compared to an estimated EPS of $. The company reported revenue of $527.48K, compared to an estimated revenue of $-.
Elevai Labs, Common Stock's current Price-to-Earnings (P/E) ratio is -914.33. The trailing twelve months (TTM) P/E ratio is -22.85. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2023, Elevai Labs, Common Stock reported total revenue of $1.71M and net income of $-4.30M. This represents a net profit margin of -2.5116954096.
Elevai Labs, Common Stock's earnings yield is -0.11%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
Elevai Labs, Common Stock's return on equity (ROE) is -112.40%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
Elevai Labs, Common Stock's gross profit margin is 66.25%. This indicates that for every dollar of revenue, the company retains $0.66 as gross profit after accounting for the cost of goods sold.
Related Metrics
Explore detailed financial metrics and analysis for ELAB.